Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion evidence source_evidence_literature NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion SIO_000772 22617708 NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion wasDerivedFrom befree-2016 NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_assertion wasGeneratedBy ECO_0000203 NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.
- befree-2016 importedOn "2016-02-19" NP984460.RAwI9CIDV--WYf0AwAZJ0tA9oz0XDbglu5BD4Llf2jgW4130_provenance.